A safe harbor from the federal Anti-Kickback Statute to protect value-based arrangements involving prescription drugs may be in the works at the US Health and Human Services Department’s Office of Inspector General, according to a proposed rule released 9 October.
The proposal lays out new anti-kickback safe harbors covering value-based and outcomes-based arrangements involving health care providers but specifically excludes...







